| Name | Title | Contact Details |
|---|
Desktop Health is a leading global provider of professional-grade 3D printing solutions. Our company invents, develops, manufactures and sells 3D printers and proprietary materials worldwide.
Park Dental Research Corp is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Greater Houston Anesthesiology (GHA) is a Texas professional association dedicated to being the leading provider of perioperative and anesthesiology services in the Houston area. GHA began operations on January 1, 1996, following the merger of six
NutraClick is a technology-driven health and wellness products company committed to enriching consumers’ lives. The company’s award-winning brands include Force Factor, Peak Life, Stages of Beauty, Bona Clara, Femme Factor, and ProbioSlim. Headquartered in Boston, Mass., NutraClick leverages the power of online marketing to drive multi-channel demand. NutraClick products are available online and in more than 30,000 retail locations globally, including GNC, CVS and Walmart. For additional information, please visit www.nutraclick.com and follow us on Twitter.